|
Wael A. Harb, MD
PUBLICATIONS:
Mundy DW, Harb
WA, Tatjana J. Radiation binary targeted therapy for Her-2 Positive
breast cancers: assumptions, theoretical assessment and future
directions. 21, FEB, 06, Phys. Med. Biol. 51 1377-1391.
Dema H. Esper,
MS, RD, CNSD1; Wael A. Harb, MD1,2,3 1.
Horizon Oncology, Lafayette, IN; 2. The Care Group LLC,
Indianapolis, IN. 3. Indiana University, Indianapolis, IN The
Cancer Cachexia Syndrome: A Review of Metabolic and Clinical
Manifestations, page 369.
Harb W, Sledge G.
(2004). Chemotherapy for Metastatic Breast Cancer. In Bland &
Copeland (Eds.), The Breast: Comprehensive Management of Benign and
Malignant Disorders. (pp. 1331). St. Louis, MO, Saunders.
CLINICAL
TRIALS:
“A Multicenter,
Open-label Phase 4 Study of XXX administered in the FIRST and
Subsequent Cycles of Myelosuppressive Chemotherapy.” 2004, PI.
“A Randomized,
Open-label, Comparative Study to Estimate the Effect of Treatment
With XXX on Hospital Days, Economic Outcomes, and Health-Related
Quality of Life in Subjects with Nonmyeloid Malignancies and Anemia
of Cancer.” 2002, PI.
“Phase II Trial
of XXX Followed by XXX Maintenance in Previously Treated Low Grade
Non-Hodgkin’s Lymphoma.” 2005, Principal Investigator. |
|
